• Implanet posted 9-month revenue of EUR 10.57 million, up 21% from EUR 8.73 million a year earlier.
• Q3 revenue reached EUR 3.44 million, up 18% from EUR 2.92 million.
• Spine implants generated EUR 6.95 million over nine months, up 15%; Q3 spine implants rose 6% to EUR 2.14 million.
• Medical equipment (SMTP) revenue totaled EUR 3.61 million, up 33%; Q3 climbed 46% to EUR 1.3 million.
• Cash stood at EUR 0.82 million on Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Implanet SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261013566283) on October 13, 2026, and is solely responsible for the information contained therein.